Candel Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 48.41% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.8%	Estuardo Aguilar-Cordova	3,155,775	US$16.3m	0%	no data
10.2%	Laura Aguilar	2,986,045	US$15.4m	0%	no data
7.92%	Paul Manning	2,323,406	US$12.0m	0%	no data
6.59%	Northpond Ventures, LLC	1,935,215	US$10.0m	0%	11.31%
2.77%	Sands Capital Ventures, LLC	811,737	US$4.2m	0%	1.35%
1.89%	Tiger Lily Capital	553,752	US$2.9m	0%	no data
1.48%	Christopher Martell	435,514	US$2.3m	0%	no data
1.45%	The Vanguard Group, Inc.	425,749	US$2.2m	5.37%	no data
1.19%	Banor Capital Ltd.	348,223	US$1.8m	0%	0.69%
1.02%	FMR LLC	298,384	US$1.5m	-32%	no data
0.47%	Geode Capital Management, LLC	139,253	US$719.9k	0%	no data
0.46%	William Nichols	135,126	US$698.6k	0%	no data
0.45%	Bridgeway Capital Management, LLC	132,595	US$685.5k	0%	0.01%
0.33%	Paul-Peter Tak	95,495	US$493.7k	133%	no data
0.27%	Charles Schoch	79,301	US$410.0k	0%	no data
0.26%	Baystate Wealth Management LLC	76,910	US$397.6k	-21%	0.03%
0.17%	BlackRock, Inc.	49,285	US$254.8k	-1.13%	no data
0.13%	Joseph Papa	38,032	US$196.6k	0%	no data
0.11%	Seshu Tyagarajan	32,872	US$169.9k	146%	no data
0.11%	Jason Amello	30,854	US$159.5k	454%	no data
0.1%	Resources Investment Advisors, Inc.	29,783	US$154.0k	17.1%	no data
0.097%	Francesca Barone	28,429	US$147.0k	938%	no data
0.094%	State Street Global Advisors, Inc.	27,600	US$142.7k	0%	no data
0.067%	Northern Trust Global Investments	19,617	US$101.4k	0%	no data
0.064%	Renaissance Technologies LLC	18,675	US$96.5k	0%	no data